GCM
NVAX icon

Graham Capital Management’s Novavax NVAX Stock Holding History

Graham Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Sell
19,336
-21,284
-52% -$193K ﹤0.01% 993
2025
Q4 		$273K Buy
40,620
+33,756
+492% +$254K 0.01% 903
2025
Q3 		$59.5K Sell
6,864
-27,130
-80% -$211K ﹤0.01% 1189
2025
Q2 		$214K Sell
33,994
-65,697
-66% -$435K ﹤0.01% 1106
2025
Q1 		$639K Buy
99,691
+38,730
+64% +$320K 0.01% 707
2024
Q4 		$490K Buy
60,961
+5,397
+10% +$52K 0.01% 745
2024
Q3 		$702K Sell
55,564
-23,375
-30% -$302K 0.01% 550
2024
Q2 		$999K Buy
+78,939
New +$794K 0.02% 423
2021
Q1 		– Sell
-37,562
Closed -$4.19M – 160
2020
Q4 		$4.19M Buy
+37,562
New +$3.99M 0.15% 83

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's NVAX Position: Q1 2026 in Review

Graham Capital Management reduced its Novavax (NVAX) stake by 52% in Q1 2026, selling an estimated $193K and leaving 19,336 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Graham Capital Management first reported a position in NVAX in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.19M in Q4 2020. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Graham Capital Management held 19,336 shares of Novavax worth $157K as of Q1 2026.
  • Graham Capital Management sold 21,284 Novavax shares in Q1 2026, an estimated $193K.
  • Novavax made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #993 holding.
  • Graham Capital Management first reported a position in Novavax in Q4 2020 and has held it in 9 quarters since.
  • Graham Capital Management's Novavax position peaked at $4.19M in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.